Roman Trawicki - Jul 1, 2021 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role: Executive Vice President
Signature: /s/ Brenda Santuccio, as Attorney-in-Fact
Stock symbol: ZTS
Transactions as of: Jul 1, 2021
Transactions value $: -$599,411
Form type: 4
Date filed: 7/6/2021, 04:22 PM
Next filing: Oct 4, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZTS	Common Stock	Options Exercise	$241K	+3.29K	+135.91%	$73.24	5.7K	Jul 1, 2021	Direct	F1
transaction	ZTS	Common Stock	Sale	-$840K	-4.49K	-78.78%	$187.00	1.21K	Jul 1, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZTS	Stock Option	Options Exercise	$0	-3.29K	-8.38%	$0.00	35.9K	Jul 1, 2021	Common Stock	3.29K		Direct	F3, F4, F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2020.
F2	The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
F3	Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
F4	3,285 options granted February 13, 2018 at an exercise price of $73.24 per option.
F5	Each option vests on the third anniversary of the date of grant.
F6	Each option expires on the tenth anniversary of the date of grant.
F7	3,287 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option.